The DOI matches its Crossref record; 329 of the 329 references it cites were found in a registry or an index.
Nucleic acid delivery for therapeutic applications
Abstract
Recent medical advances have exploited the ability to address a given disease at the underlying level of transcription and translation. These treatment paradigms utilize nucleic acids - including short interfering RNA (siRNA), microRNA (miRNA), antisense oligonucleotides (ASO), and messenger RNA (mRNA) - to achieve a desired outcome ranging from gene knockdown to induced expression of a selected target protein. Towards this end, numerous strategies for encapsulation or stabilization of various nucleic acid structures have been developed in order to achieve intracellular delivery. In this review, we discuss several therapeutic applications of nucleic acids directed towards specific diseases and tissues of interest, in particular highlighting recent technologies which have reached late-stage clinical trials and received FDA approval.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–329 of 329
Shirley, M. (2021) · Drugs · doi:10.1007/s40265-021-01512-2 · Cited by 274
Tebas, P., Yang, S., Boyer, J. D., Reuschel, E. L., Patel, A., Christensen-Quick, A., Andrade, V. M., Morrow, M. P., Kraynyak, K., Agnes, J., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100689 · Cited by 270
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease
Richner, J. M., Jagger, B. W., Shan, C., Fontes, C. R., Dowd, K. A., Cao, B., Himansu, S., Caine, E. A., Nunes, B. T. D., Medeiros, D. B. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.040 · Cited by 267
Human Glioma Growth Is Controlled by MicroRNA-10b
Gabriely, G., Yi, M., Narayan, R. S., Niers, J. M., Wurdinger, T., Imitola, J., Ligon, K. L., Kesari, S., Esau, C., Stephens, R. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3568 · Cited by 266
Vaidyanathan, S., Azizian, K. T., Haque, A. K. M. A., Henderson, J. M., Hendel, A., Shore, S., Antony, J. S., Hogrefe, R. I., Kormann, M. S. D., Porteus, M. H., et al. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.010 · Cited by 262
An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
Li, B., Luo, X., Deng, B., Wang, J., McComb, D. W., Shi, Y., Gaensler, K. M. L., Tan, X., Dunn, A. L., Kerlin, B. A., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03528 · Cited by 261
Schultheis, B., Strumberg, D., Santel, A., Vank, C., Gebhardt, F., Keil, O., Lange, C., Giese, K., Kaufmann, J., Khan, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0376 · Cited by 260
Lipid nanoparticles for delivery of messenger RNA to the back of the eye
Patel, S., Ryals, R. C., Weller, K. K., Pennesi, M. E., & Sahay, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.015 · Cited by 260
DNA antisense therapy for asthma in an animal model
Nyce, J. W., & Metzger, W. J. (1997) · Nature · doi:10.1038/385721a0 · Cited by 257
Differentiation and function of Kupffer cells
Naito, M., Hasegawa, G., Ebe, Y., & Yamamoto, T. (2004) · Medical Electron Microscopy · doi:10.1007/s00795-003-0228-x · Cited by 252
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery
Fenton, O. S., Kauffman, K. J., McClellan, R. L., Appel, E. A., Dorkin, J. R., Tibbitt, M. W., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2016) · Advanced Materials · doi:10.1002/adma.201505822 · Cited by 252
Self-citationPollard, C., Rejman, J., De Haes, W., Verrier, B., Van Gulck, E., Naessens, T., De Smedt, S., Bogaert, P., Grooten, J., Vanham, G., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.202 · Cited by 248
Rappolt, M., Hickel, A., Bringezu, F., & Lohner, K. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)70036-8 · Cited by 247
DEVINCENZO, J., CEHELSKY, J., ALVAREZ, R., ELBASHIR, S., HARBORTH, J., TOUDJARSKA, I., NECHEV, L., MURUGAIAH, V, VLIET, A., & VAISHNAW, A. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.009 · Cited by 247
Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
Corey, D. R. (2017) · Nature Neuroscience · doi:10.1038/nn.4508 · Cited by 240
Locked nucleic acid: modality, diversity, and drug discovery
Hagedorn, P. H., Persson, R., Funder, E. D., Albæk, N., Diemer, S. L., Hansen, D. J., Møller, M. R., Papargyri, N., Christiansen, H., Hansen, B. R., et al. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2017.09.018 · Cited by 238
Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers
Park, M. R., Han, K. O., Han, I. K., Cho, M. H., Nah, J. W., Choi, Y. J., & Cho, C. S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.008 · Cited by 236
Grzelinski, M., Urban-Klein, B., Martens, T., Lamszus, K., Bakowsky, U., Höbel, S., Czubayko, F., & Aigner, A. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.751 · Cited by 234
Long-term storage of lipid-like nanoparticles for mRNA delivery
Zhao, P., Hou, X., Yan, J., Du, S., Xue, Y., Li, W., Xiang, G., & Dong, Y. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.03.001 · Cited by 233
Schnee, M., Vogel, A. B., Voss, D., Petsch, B., Baumhof, P., Kramps, T., & Stitz, L. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004746 · Cited by 230
Ottosen, S., Parsley, T. B., Yang, L., Zeh, K., van Doorn, L.-J., van der Veer, E., Raney, A. K., Hodges, M. R., & Patick, A. K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04220-14 · Cited by 230
Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production
Charleston, J. S., Schnell, F. J., Dworzak, J., Donoghue, C., Lewis, S., Chen, L., Young, G. D., Milici, A. J., Voss, J., DeAlwis, U., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005680 · Cited by 230
Rapidly produced SAM ® vaccine against H7N9 influenza is immunogenic in mice
Hekele, A., Bertholet, S., Archer, J., Gibson, D. G., Palladino, G., Brito, L. A., Otten, G. R., Brazzoli, M., Buccato, S., Bonci, A., et al. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.54 · Cited by 226
Weleber, R. G., Pennesi, M. E., Wilson, D. J., Kaushal, S., Erker, L. R., Jensen, L., McBride, M. T., Flotte, T. R., Humphries, M., Calcedo, R., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.03.003 · Cited by 218
Ahmadzada, T., Reid, G., & McKenzie, D. R. (2018) · Biophysical Reviews · doi:10.1007/s12551-017-0392-1 · Cited by 214
Luxturna: FDA documents reveal the value of a costly gene therapy
Darrow, J. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.01.019 · Cited by 213
RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
Zamora, M. R., Budev, M., Rolfe, M., Gottlieb, J., Humar, A., DeVincenzo, J., Vaishnaw, A., Cehelsky, J., Albert, G., Nochur, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0422oc · Cited by 210
Paunovska, K., Da Silva Sanchez, A. J., Sago, C. D., Gan, Z., Lokugamage, M. P., Islam, F. Z., Kalathoor, S., Krupczak, B. R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201807748 · Cited by 205
How mRNA therapeutics are entering the monoclonal antibody field
Van Hoecke, L., & Roose, K. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1804-8 · Cited by 205
Li, M., Zhao, M., Fu, Y., Li, Y., Gong, T., Zhang, Z., & Sun, X. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.043 · Cited by 201
Kremsner, P., Mann, P., Bosch, J., Fendel, R., Gabor, J. J., Kreidenweiss, A., Kroidl, A., Leroux-Roels, I., Leroux-Roels, G., Schindler, C., et al. (2020) · doi:10.1101/2020.11.09.20228551 · Cited by 199
Polymers in Small-Interfering RNA Delivery
Singha, K., Namgung, R., & Kim, W. J. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0293 · Cited by 198
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Cortez, M. A., Valdecanas, D., Zhang, X., Zhan, Y., Bhardwaj, V., Calin, G. A., Komaki, R., Giri, D. K., Quini, C. C., Wolfe, T., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.79 · Cited by 196
The effects of PEGylation on LNP based mRNA delivery to the eye
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241006 · Cited by 194
Diken, M., Kreiter, S., Selmi, A., Britten, C. M., Huber, C., Türeci, Ö., & Sahin, U. (2011) · Gene Therapy · doi:10.1038/gt.2011.17 · Cited by 192
de Alwis, R., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Low, J. G. H., Kalimuddin, S., Matsuda, D., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.001 · Cited by 191
Immune mechanisms in inflammatory and degenerative eye disease
Perez, V. L., & Caspi, R. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.003 · Cited by 188
Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2 + Breast Cancer Growth and Metastasis
Yao, Y.-D., Sun, T.-M., Huang, S.-Y., Dou, S., Lin, L., Chen, J.-N., Ruan, J.-B., Mao, C.-Q., Yu, F.-Y., Zeng, M.-S., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003601 · Cited by 188
Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination
Persano, S., Guevara, M. L., Li, Z., Mai, J., Ferrari, M., Pompa, P. P., & Shen, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.019 · Cited by 187
Fomivirsen – a phosphorothioate oligonucleotide for the treatment of CMV retinitis
de Smet, M. D., Meenken, C., & van den Horn, G. J. (1999) · Ocular Immunology and Inflammation · doi:10.1076/ocii.7.3.189.4007 · Cited by 187
Al-Zaidy, S. A., Kolb, S. J., Lowes, L., Alfano, L. N., Shell, R., Church, K. R., Nagendran, S., Sproule, D. M., Feltner, D. E., Wells, C., et al. (2019) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-190403 · Cited by 185
Zhou, K., Nguyen, L. H., Miller, J. B., Yan, Y., Kos, P., Xiong, H., Li, L., Hao, J., Minnig, J. T., Zhu, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520756113 · Cited by 183
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Zhang, X., Zhao, W., Nguyen, G. N., Zhang, C., Zeng, C., Yan, J., Du, S., Hou, X., Li, W., Jiang, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc2315 · Cited by 182
Bogers, W. M., Oostermeijer, H., Mooij, P., Koopman, G., Verschoor, E. J., Davis, D., Ulmer, J. B., Brito, L. A., Cu, Y., Banerjee, K., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu522 · Cited by 181
Shoji, Y., Akhtar, S., Periasamy, A., Herman, B., & Juliano, R. L. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5543 · Cited by 178
Biomaterials for mRNA delivery
Islam, M. A., Reesor, E. K. G., Xu, Y., Zope, H. R., Zetter, B. R., & Shi, J. (2015) · Biomaterials Science · doi:10.1039/c5bm00198f · Cited by 176
Effects of Chemically Modified Messenger RNA on Protein Expression
Li, B., Luo, X. L., & Dong, Y. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00090 · Cited by 174
Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells
Kim, C. H., Oh, Y., & Lee, T. H. (1997) · Gene · doi:10.1016/s0378-1119(97)00384-3 · Cited by 172
Crooke, S. T., & Geary, R. S. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04469.x · Cited by 171
Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer
Daige, C. L., Wiggins, J. F., Priddy, L., Nelligan-Davis, T., Zhao, J., & Brown, D. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0209 · Cited by 168
Garbuzenko, O. B., Saad, M., Betigeri, S., Zhang, M., Vetcher, A. A., Soldatenkov, V. A., Reimer, D. C., Pozharov, V. P., & Minko, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9755-4 · Cited by 167
Zhu, X., Yin, L., Theisen, M., Zhuo, J., Siddiqui, S., Levy, B., Presnyak, V., Frassetto, A., Milton, J., Salerno, T., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.02.003 · Cited by 165
Rauch, S., Roth, N., Schwendt, K., Fotin-Mleczek, M., Mueller, S. O., & Petsch, B. (2021) · npj Vaccines · doi:10.1038/s41541-021-00311-w · Cited by 165
Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic)Acid Microspheres
Carrasquillo, K. G., Ricker, J. A., Rigas, I. K., Miller, J. W., Gragoudas, E. S., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.01-1156 · Cited by 163
Erasmus, J. H., Khandhar, A. P., Guderian, J., Granger, B., Archer, J., Archer, M., Gage, E., Fuerte-Stone, J., Larson, E., Lin, S., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.010 · Cited by 161
Zhou, J., Neff, C. P., Liu, X., Zhang, J., Li, H., Smith, D. D., Swiderski, P., Aboellail, T., Huang, Y., Du, Q., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.207 · Cited by 161
Chahal, J. S., Fang, T., Woodham, A. W., Khan, O. F., Ling, J., Anderson, D. G., & Ploegh, H. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-00193-w · Cited by 161
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
McClorey, G., & Banerjee, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020051 · Cited by 160
Stahlhut, C. E., & Slack, F. J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1003008 · Cited by 155
Brazzoli, M., Magini, D., Bonci, A., Buccato, S., Giovani, C., Kratzer, R., Zurli, V., Mangiavacchi, S., Casini, D., Brito, L. M., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01786-15 · Cited by 154
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
Tiwari, P. M., Vanover, D. A., Lindsay, K. E., Bawage, S. S., Kirschman, J. L., Bhosle, S. M., Lifland, A. W., Zurla, C., & Santangelo, P. J. (2018) · Nature Communications · doi:10.1038/s41467-018-06508-3 · Cited by 150
Alvarez, R., Elbashir, S. M., Borland, T. D., Toudjarska, I., Hadwiger, P., John, M., Roehl, I., Shulga‐Morskaya, S., Martinello, R., Kahn, J. S., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00014-09 · Cited by 149
Haabeth, O. A. W., Blake, T. R., McKinlay, C. J., Waymouth, R. M., Wender, P. A., & Levy, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810002115 · Cited by 148
Ryckbosch, S. M., Wender, P. A., & Pande, V. S. (2017) · Nature Communications · doi:10.1038/s41467-016-0015-8 · Cited by 147
Nanotechnology for therapy and imaging of liver diseases
Reddy, L. H., & Couvreur, P. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.039 · Cited by 145
Kowalski, P. S., Palmiero, U. C., Huang, Y., Rudra, A., Langer, R., & Anderson, D. G. (2018) · Advanced Materials · doi:10.1002/adma.201801151 · Cited by 145
Self-citationmRNA as novel technology for passive immunotherapy
Schlake, T., Theß, A., Thran, M., & Jordan, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2935-4 · Cited by 143
Gene Therapy for Spinal Muscular Atrophy: Safety and Early Outcomes
Waldrop, M. A., Karingada, C., Storey, M. A., Powers, B. R., Iammarino, M. A., Miller, N. F., Alfano, L. N., Noritz, G. H., Rossman, I. T., Ginsberg, M., et al. (2020) · PEDIATRICS · doi:10.1542/peds.2020-0729 · Cited by 137
Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA
Zhao, M., Li, M., Zhang, Z., Gong, T., & Sun, X. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1038856 · Cited by 132
Abbink, P., Stephenson, K. E., & Barouch, D. H. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0039-7 · Cited by 130
Dika, I. E., Lim, H. Y., Yong, W. P., Lin, C., Yoon, J., Modiano, M., Freilich, B. L., Choi, H. J., Chao, T.-Y., Kelley, R. K., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0838 · Cited by 130
Chan, A., Liebow, A., Yasuda, M., Gan, L., Racie, T., Maier, M., Kuchimanchi, S., Foster, D., Milstein, S., Charisse, K., et al. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.36 · Cited by 128
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
Phua, K. K. L., Staats, H. F., Leong, K. W., & Nair, S. K. (2014) · Scientific Reports · doi:10.1038/srep05128 · Cited by 127
Rajala, A., Wang, Y., Zhu, Y., Ranjo‐Bishop, M., Ma, J., Mao, C., & Rajala, R. V. S. (2014) · Nano Letters · doi:10.1021/nl502275s · Cited by 126
Echigoya, Y., Nakamura, A., Nagata, T., Urasawa, N., Lim, K. R. Q., Trieu, N., Panesar, D., Kuraoka, M., Moulton, H. M., SAITO, T. K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613203114 · Cited by 126
Ganesh, S., Shui, X., Craig, K. P., Park, J., Wang, W., Brown, B. D., & Abrams, M. T. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.09.005 · Cited by 126
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
Fusco, D. D., Dinallo, V., Marafini, I., Figliuzzi, M. M., Romano, B., & Monteleone, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00305 · Cited by 126
A thermostable messenger RNA based vaccine against rabies
Stitz, L., Vogel, A., Schnee, M., Voss, D., Rauch, S., Mutzke, T., Ketterer, T., Kramps, T., & Petsch, B. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006108 · Cited by 117
Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
Dong, Y., Dorkin, J. R., Wang, W., Chang, P., Webber, M. J., Tang, B. C., Yang, J., Ionita, I. A., Danino, D., DeRosa, F., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b02428 · Cited by 114
Self-citationVerbeke, R., Lentacker, I., Breckpot, K., Janssens, J., Calenbergh, S. V., Smedt, S. C. D., & Dewitte, H. (2019) · ACS Nano · doi:10.1021/acsnano.8b07660 · Cited by 113
First AAV gene therapy poised for landmark approval
Smalley, E. (2017) · Nature Biotechnology · doi:10.1038/nbt1117-998 · Cited by 112
Systemic mRNA delivery to the lungs by functional polyester-based carriers
Yan, Y., Xiong, H., Zhang, X., Cheng, Q., & Siegwart, D. J. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01356 · Cited by 111
Immune response following intraocular delivery of recombinant viral vectors
Bennett, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302030 · Cited by 111
Structure and Function of Argonaute Proteins
Hall, T. M. T. (2005) · Structure · doi:10.1016/j.str.2005.08.005 · Cited by 107
Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
Moss, K. H., Popova, P. G., Hadrup, S. R., Astakhova, K., & Taskova, M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01290 · Cited by 104
Khan, O. F., Zaia, E. W., Yin, H., Bogorad, R. L., Pelet, J. M., Webber, M. J., Zhuang, I., Dahlman, J. E., Langer, R., & Anderson, D. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408221 · Cited by 101
Self-citationA Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA
Saunders, N., Paolini, M. S., Fenton, O. S., Poul, L., Devallière, J., Mpambani, F., Darmon, A., Bergère, M., Jibault, O., Germain, M., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00752 · Cited by 100
Self-citationOptimized siRNA-PEG Conjugates for Extended Blood Circulation and Reduced Urine Excretion in Mice
Iversen, F., Yang, C., Dagnæs‐Hansen, F., Schaffert, D., Kjems, J., & Gao, S. (2013) · Theranostics · doi:10.7150/thno.5743 · Cited by 99
Delivery of Therapeutic siRNA to the Lung Endothelium via Novel Lipoplex Formulation DACC
Fehring, V., Schaeper, U., Ahrens, K., Santel, A., Keil, O., Eisermann, M., Giese, K., & Kaufmann, J. (2014) · Molecular Therapy · doi:10.1038/mt.2013.291 · Cited by 98
Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells
Burchett, K. M., Yan, Y., & Ouellette, M. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085155 · Cited by 95
Chen, C., Lu, D., Yeh, Y., Shiau, & Chiang (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24447 · Cited by 95
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Mathew, V., & Wang, A. K. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s162913 · Cited by 95
Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination
Son, S., Nam, J., Zenkov, I., Ochyl, L. J., Xu, Y., Scheetz, L. M., Shi, J., Farokhzad, O. C., & Moon, J. J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b03483 · Cited by 95
Schluep, T., Lickliter, J. D., Hamilton, J., Lewis, D. L., Lai, C., Lau, J. Y. N., LOCARNINI, S. A., Gish, R. G., & Given, B. D. (2016) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.318 · Cited by 92
DNA nanoparticles for ophthalmic drug delivery
de Vries, J. W., Schnichels, S., Hurst, J., Strudel, L., Gruszka, A., Kwak, M., Bartz‐Schmidt, K. U., Spitzer, M. S., & Herrmann, A. P. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.046 · Cited by 91
Tao, J., Zhang, R., Singh, S., Poddar, M., Xu, E., Oertel, M., Chen, X., Ganesh, S., Abrams, M. T., & Monga, S. P. (2016) · Hepatology · doi:10.1002/hep.28975 · Cited by 86
Popplewell, L. J., Trollet, C., Dickson, G., & Graham, I. R. (2009) · Molecular Therapy · doi:10.1038/mt.2008.287 · Cited by 83
Kirschman, J. L., Bhosle, S. M., Vanover, D. A., Blanchard, E. L., Loomis, K. H., Zurla, C., Murray, K. A., Lam, B. C., & Santangelo, P. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx290 · Cited by 80
Onasemnogene abeparvovec for spinal muscular atrophy: The costlier drug ever
Mahajan, R. (2019) · International Journal of Applied and Basic Medical Research · doi:10.4103/ijabmr.ijabmr_190_19 · Cited by 76
Patil, T. S., & Deshpande, A. S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.070 · Cited by 75
McCullough, K. C., Bassi, I., Milona, P., Suter, R., Thomann, L., Englezou, P. C., Démoulins, T., & Ruggli, N. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.24 · Cited by 72
TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge
Imaoka, H., Campbell, H., Babirad, I., Watson, R. M., Mistry, M., Sehmi, R., & Gauvreau, G. M. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03816.x · Cited by 68
Espinosa, D. A., Christensen, D., Muñoz, C. A., Singh, S. P., Locke, E., Andersen, P. L., & Zavala, F. P. (2017) · npj Vaccines · doi:10.1038/s41541-017-0011-y · Cited by 68
Chow, M. Y. T., Qiu, Y., Lo, F. F. K., Lin, H. H. S., Chan, H., Kwok, P. C. L., & Lam, J. K. W. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.013 · Cited by 68
Therapeutic RNA Delivery for COVID and Other Diseases
Dobrowolski, C. N., Paunovska, K., Hatit, M. Z. C., Lokugamage, M. P., & Dahlman, J. E. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002022 · Cited by 65
Backer, L. D., Cerrada, A., Pérez‐Gil, J., Smedt, S. C. D., & Raemdonck, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.004 · Cited by 64
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin
Ganesh, S., Koser, M. L., Cyr, W. A., Chopda, G. R., Tao, J., Shui, X., Ying, B., Chen, D., Pandya, P., Chipumuro, E., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0309 · Cited by 64
Ni, S., Liu, Y., Tang, Y., Chen, J., Li, S., Pu, J., & Han, L. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.09.075 · Cited by 61
ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection
Thi, E. P., Dhillon, A. P., Ardzinski, A., Bidirici-Ertekin, L., Cobarrubias, K. D., Cuconati, A., Kondratowicz, A. S., Kwak, K., Li, A. H. L., Miller, A., et al. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00191 · Cited by 61
Biscans, A., Coles, A. H., Echeverria, D., & Khvorova, A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.028 · Cited by 61
Cytosolic delivery of proteins by cholesterol tagging
Tai, W., Zhao, P., & Gao, X. (2020) · Science Advances · doi:10.1126/sciadv.abb0310 · Cited by 59
Yanagi, T., Tachikawa, K., Wilkie-Grantham, R. P., Hishiki, A., Nagai, K., Toyonaga, E., Chivukula, P., & Matsuzawa, S. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.40 · Cited by 57
Chi, K. N., Zoubeidi, A., & Gleave, M. E. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802528609 · Cited by 56
Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles
Caracciolo, G., Pozzi, D., Capriotti, A. L., Cavaliere, C., & Laganà, A. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1498-4 · Cited by 51
Synthesis, Characterization, and Evaluation of Ionizable Lysine-Based Lipids for siRNA Delivery
Walsh, C. L., Nguyen, J., Tiffany, M. R., & Szoka, F. C. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300346h · Cited by 51
Schultheis, B. S., Strumberg, D., Kuhlmann, J. B., Wolf, M., Link, K., Seufferlein, T. T. W., Kaufmann, J., Gebhardt, F., Bruyniks, N., & Pelzer, U. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.4_suppl.385 · Cited by 45
Development of Cationic Quaternary Ammonium Sulfonamide Amino Lipids for Nucleic Acid Delivery
Miller, J. B., Kós, P., Tieu, V., Zhou, K., & Siegwart, D. J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b15982 · Cited by 44
Belfort, R., Da, G., Johnson, D. W., Mansour, S., Muccioli, C., Sheppard, J., Mora-Durate, J., Chan, C., Palestine, A., Perez, J. E. A., et al. (2002) · UCL Discovery (University College London) · Cited by 41
Incorporation of high molecular weight RNA into large artificial lipid vesicles
Ostro, M. J., Giacomoni, D., & Dray, S. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)91576-5 · Cited by 34
Entrapment of ribonucleic acids in liposomes
Dimitriadis, G. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80582-1 · Cited by 34
Beumer, W., Swildens, J., Leal, T., Noël, S., Anthonijsz, H. J. A., van der Horst, G., Kuiperij-Boersma, H., Potman, M., van Putten, C., Biasutto, P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219182 · Cited by 32
Allison, S. J., & Milner, J. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.68 · Cited by 31
Ye, X., Tateno, C., Thi, E. P., Kakuni, M., Snead, N. M., Ishida, Y., Barnard, T. R., Sofia, M. J., Shimada, T., & Lee, A. C. H. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00192 · Cited by 30
Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
Kalnin, K. V., Plitnik, T., Kishko, M., Zhang, J., Zhang, D., Beauvais, A., Anosova, N. G., Tibbitts, T., DiNapoli, J. M., Huang, P.-W. D., et al. (2020) · doi:10.1101/2020.10.14.337535 · Cited by 18
Wooddell, C. I., Zhu, R., Hamilton, H. L., Chu, Q., Sternard, H., Schumacher, J., Schluep, T., Seefeld, M. A., Li, Z., & Given, B. D. (2018) · Journal of Hepatology · doi:10.1016/s0168-8278(18)30255-1 · Cited by 16
Wrangling RNA: Antisense oligonucleotides for neurological disorders
Talbot, K., & Wood, M. J. A. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay2069 · Cited by 14
Nyce, J. W. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.9.1149 · Cited by 14
Chemical and Biological Approaches to Regenerative Medicine and Tissue Engineering
Langer, R. (2019) · Molecular Frontiers Journal · doi:10.1142/s2529732519400091 · Cited by 10
Self-citationPaunovska, K., Sanchez, A. J. D. S., Sago, C. D., Gan, Z., Lokugamage, M. P., Islam, F. Z., Kalathoor, S., Krupczak, B. R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201970098 · Cited by 7
Cited by
The landscape of mRNA nanomedicine
Huang, X., Kong, N., Zhang, X., Cao, Y., Langer, R., & Tao, W. (2022) · Nature Medicine · doi:10.1038/s41591-022-02061-1 · Cited by 511
Self-citationBai, R., Li, Y., Jian, L., Yang, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 279
GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases
Qin, Z.-X., Zuo, L., Zeng, Z., Ma, R., Xie, W., Zhu, X., & Zhou, X. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2466767 · Cited by 32
Chen, H., Guo, L., Ding, J., Zhou, W., & Qi, Y. (2023) · Advanced Science · doi:10.1002/advs.202302620 · Cited by 31
Tian, Y., Sun, D., Liu, N., Zhao, J., Zhao, T., Liu, X., Dong, X., Dong, L., Wang, W., Jiao, P., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03029-8 · Cited by 14
Metadata
- Authors
- Gupta, A., Andresen, J. L., Manan, R. S., & Langer, R.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 178
- Pages
- 113834
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3196815974
- Cited by
- 331
- References
- 329
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.